Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

    Virtual Booth

    Contact Supplier

    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    China

    Virtual Booth

    Contact Supplier

    Menu

    Radiprodil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 148,589Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Epilepsy Biotech Nabs up to $570M in Deal With Angelini
    Epilepsy Biotech Nabs up to $570M in Deal With Angelini

    28 May 2025

    // BIOSPACW

    https://www.biospace.com/deals/epilepsy-biotech-nabs-up-to-570m-in-deal-with-italys-angelini-plus-140m-fundraising

    BIOSPACW
    28 May 2025
    Share Share
    GRIN Therapeutics Gets EU Orphan Designation for Radiprodil
    GRIN Therapeutics Gets EU Orphan Designation for Radiprodil

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-positive-opinion-for-eu-orphan-designation-for-radiprodil-for-treatment-of-grin-related-neurodevelopmental-disorder-302446917.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    GRIN Therapeutics Receives PRIME Designation from EMA for Radiprodil
    GRIN Therapeutics Receives PRIME Designation from EMA for Radiprodil

    01 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-priority-medicines-prime-designation-from-ema-for-radiprodil-in-the-treatment-of-grin-related-neurodevelopmental-disorder-302416531.html

    PR NEWSWIRE
    01 Apr 2025
    Share Share
    GRIN Therapeutics gets FDA Orphan Drug Designation for Radiprodil
    GRIN Therapeutics gets FDA Orphan Drug Designation for Radiprodil

    17 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-fda-orphan-drug-designation-for-radiprodil-for-the-treatment-of-grin-related-neurodevelopmental-disorder-302402623.html

    PR NEWSWIRE
    17 Mar 2025
    Share Share
    GRIN Therapeutics gets FDA Breakthrough Therapy for Radiprodil
    GRIN Therapeutics gets FDA Breakthrough Therapy for Radiprodil

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-receives-fda-breakthrough-therapy-designation-for-radiprodil-302384417.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    GRIN Therapeutics Presents Honeycomb Trial Data of Radiprodil
    GRIN Therapeutics Presents Honeycomb Trial Data of Radiprodil

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grin-therapeutics-presents-data-from-honeycomb-trial-of-radiprodil-at-the-american-epilepsy-society-annual-meeting-302324666.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share